24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Congress
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:41
Adam Singolda: “This past year, we realized we’ve been walking among wolves—but now I know who my true friends are”
10:06
Gili Raanan: “I don't believe there is a bubble in cyber”
08:38
CTech’s Book Review: The guide to stellar sales
17:49
EU antitrust chief Vestager ends with wins over Apple and Google, but is it enough?
More stories
Buzz
Most popular
Daily
Weekly
1
Cyber unicorn Checkmarx hits the market with $2.5 billion price tag
2
"We closed a deal with a large client, but they had questions about what happens if Israel no longer exists"
3
Andreessen Horowitz steps up Israeli investments as local funds struggle to raise capital
4
Mobileye drops lidar development, axes 100 jobs to save $60M
5
The Gili Ra’anan model: Questions emerging from Cyberstarts' remarkable success
More news
Congress
4 stories about Congress
A house divided: Congress shockwaves will hit Israel
05.10.23
|
Adrian Filut
Government bond yields in the US - the security that reflects the level of confidence or lack of confidence in the local economy - jumped this week to a 16-year high and to levels seen immediately before the financial crisis in 2008; The jump in yields makes money more expensive and destabilizes the economy, and it seems that the reasons behind this will not disappear soon
Post-U.S. elections – what can high-tech companies expect?
09.11.20
|
Adv. Joeri Kreisberg and Daniel Ritter
Everyhing from Green Technology, Healthcare, AI, and Space - it's all on the table until 2024
U.S. senators aim to stop sale of drugs online by going after tech's legal immunity
29.09.20
|
Reuters
There are several pieces of legislation targeting Section 230 being introduced from both Democrats and Republicans
U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices
21.08.17
|
Dror Reich
Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies
Please ensure Javascript is enabled for purposes of
website accessibility